YAP antagonizes TEAD-mediated AR signaling and prostate cancer growth

Abstract

Hippo signaling restricts tumor growth by inhibiting the oncogenic potential of YAP/TAZ-TEAD transcriptional complex. Here we uncover a context-dependent tumor suppressor function of YAP in androgen receptor (AR) positive prostate cancer (PCa) and show that YAP impedes AR+ PCa growth by antagonizing TEAD-mediated AR signaling. TEAD forms a complex with AR to enhance its promoter/enhancer occupancy and transcriptional activity. YAP and AR compete for TEAD binding and consequently, elevated YAP in the nucleus disrupts AR-TEAD interaction and prevents TEAD from promoting AR signaling. Pharmacological inhibition of Hippo/MST1/2 kinase or transgenic activation of YAP suppressed the growth of PCa expressing therapy resistant AR splicing variants. Our study uncovers an unanticipated crosstalk between Hippo and AR signaling pathways, reveals an antagonistic relationship between YAP and TEAD in AR+ PCa, and suggests that targeting the Hippo signaling pathway may provide a therapeutical opportunity to treat PCa driven by therapy resistant AR variants. O_LIYAP acts as a context-dependent tumor suppressor in AR+ PCa C_LIO_LITEAD interacts with AR to enhance its promoter/enhancer occupancy C_LIO_LIYAP inhibits AR activity by competing for TEAD binding C_LIO_LISmall molecule Hippo pathway inhibitor impedes AR+ PCa growth C_LI